Traditionally, quality management in the pharmaceutical industry has strayed away from artificial intelligence (AI) for fear of setting it loose with such sensitive information. They have been cautious of implementing an additional element of intelligence into their process. But will organizations turn a new leaf this coming year to keep up with innovations?

At IQVIA, we have thought a lot about the future of the industry and how innovative technology might be incorporated. Certainly, the industry has begun to leverage large language models (LLM) and other capabilities of AI, a trend that is expected to continue in 2024. Additionally, the use of recommendation engines will increase because they enable a combination of AI and personal experience, focusing on augmented intelligence as opposed to AI alone. Recommendation engines can greatly improve responsiveness, cycle times, accuracy, and efficiency, making a significant impact on productivity.

 …